Daily Archives:
November 21st, 2013


  1. Ben Franklin Alumnus OraSure Technologies Announces New Agreement with Thermo Fisher Scientific

    OraSure Technologies, Inc. (NASDAQ:OSUR) has reached an agreement with Thermo Fisher Scientific to develop and supply up to 12 homogenous fully automated oral fluid drugs of abuse assays to be used with a new Intercept® oral fluid specimen collection device. OraSure’s current Intercept® Oral Fluid Drug Testing System was the first FDA-cleared in-vitro diagnostic laboratory-based Continue Reading…

  2. Founder of Ben Franklin Alumnus Viddler Profiled in Keystone Edge

    At about the same time YouTube was getting started, Donna DeMarco and her business partner had an idea for technology that would allow people to interact with videos for educational purposes. Read more.

  3. Ben Franklin client Azevan is developing novel treatments for stress, mood and behavioral disorders

    The company’s most advanced compound, SRX246, a treatment for intermittent explosive disorder, will begin phase-two, clinical trials in the first quarter of 2014. Azevan is also developing treatment for anger, aggression and impulse control disorders, which often spring from traumatic brain injury, attention deficit hyperactivity disorder, post-traumatic stress disorder (PTSD) and personality disorders. Read more.